Company
Team
CORPORATE GOVERNANCE
Platforms
Glycovirology
Degenerative Diseases
pipeline
ProLectin Pipeline
Degenerative Disease pipeline
Resources
IN THE NEWS
Stroke video
faq
SCIENTIFIC PUBLICATIONS
investors
Company presentation
press releases
Reports
financial
Contact US
$BIXT
Company
Platforms
Glycovirology
Degenerative Diseases
Resources
Investors
Pipeline
contact us
Glycovirology Scientific Publications
featured
Galectin approach to lower covid transmission - Drug Development for clinical use
Galectin approach to lower covid transmission - Drug Development for clinical use
A Multi-Targeting Approach to Fight SARS-CoV-2 Attachment
A Multi-Targeting Approach to Fight SARS-CoV-2 Attachment
Galectin-3 as prognostic biomarker in patients with COVID-19 acute respiratory failure
Galectin-3 as prognostic biomarker in patients with COVID-19 acute respiratory failure
Previous
load more
Galectin-1 Binds to Influenza Virus and Ameliorates Influenza Virus Pathogenesis
Galectin-1 Binds to Influenza Virus and Ameliorates Influenza Virus Pathogenesis
Beneficial Effects of Mineralocorticoid Receptor Pathway Blockade against Endothelial Inflammation Induced by SARS-CoV-2 Spike Protein
Beneficial Effects of Mineralocorticoid Receptor Pathway Blockade against Endothelial Inflammation Induced by SARS-CoV-2 Spike Protein
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection
Galectin-9 Regulates The Threshold of B Cell Activation and Autoimmunity
Galectin-9 Regulates The Threshold of B Cell Activation and Autoimmunity
Previous
load more
go back